Thrombocytopenia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m Template |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thrombocytopenia}} | {{Thrombocytopenia}} | ||
{{CMG}} | {{CMG}} {{shyam}} | ||
==Overview== | ==Overview== | ||
Secondary prevention measures include the avoidance of viruses of medications that can precipitate low platelet counts. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention measures include the avoidance of viruses of medications that can precipitate low platelet counts. | |||
==References== | ==References== | ||
Latest revision as of 01:57, 20 December 2018
|
Thrombocytopenia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thrombocytopenia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Thrombocytopenia secondary prevention |
|
Risk calculators and risk factors for Thrombocytopenia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Overview
Secondary prevention measures include the avoidance of viruses of medications that can precipitate low platelet counts.
Secondary Prevention
Secondary prevention measures include the avoidance of viruses of medications that can precipitate low platelet counts.